SEP 10·SEC EDGARLow
BAKER DANIEL A sold $2.1M of NVEC
BAKER DANIEL A sold 21,140 shares of NVE CORP /NEW/ (NVEC) at an average of $101.49 ($101.00–$101.54, $2.15M total) across 2 trades on 2026-09-08.
StockNASDAQ · US · USDTechnology · Semiconductors
$NVEC
NVE CORP /NEW/
Price · $NVECvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $NVEC in the last 7 days.
Insider · 30dAll trades →
- Buys
- — 0 txs
- Sells
- $3.0M 6 txs
BAKER DANIEL A6× · $3.0M
10b5-1 share of filings0%
Top stories · $NVECMore →
AUG 27·SEC EDGAR
BAKER DANIEL A sold $623K of NVEC
BAKER DANIEL A sold 5,731 shares of NVE CORP /NEW/ (NVEC) at an average of $108.74 ($107.00–$110.00, $0.62M total) across 3 trades over 2026-08-25 to 2026-08-27.
AUG 19·SEC EDGAR
BAKER DANIEL A sold $182K of NVEC
BAKER DANIEL A sold 1,500 shares of NVE CORP /NEW/ (NVEC) at $121.50 ($0.18M total) on 2026-08-17.
NVEC sentiment & insider activity
Recent NVEC coverage spans insider activity, earnings and corporate actions.
In the last 30 days, NVEC insiders filed 6 SEC Form 4 transactions — no purchases and 6 sales ($3.0M). The most active reporter was BAKER DANIEL A with 6 filings.
What's driving NVEC
The insider sale may signal limited confidence from a director, potentially pressuring the stock lower in the short term.
Insider sale by a director may signal lack of confidence, potentially pressuring the stock.
Minor dilution of insider confidence; likely limited price impact.
Board and executive leadership changes can shift investor expectations around strategy and execution, but the filing provides no financial guidance or operational metrics.
The catalyst in the text is the sharp price move plus prior Q1 improvement, but no fresh Q2 datapoint is provided.
AlphAI scores every news story that mentions NVEC with an AI model for sentiment and relevance, and aggregates insider trades from NVE CORP /NEW/'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $NVEC
Score
BAKER DANIEL A sold $2.1M of NVEC
BAKER DANIEL A sold 21,140 shares of NVE CORP /NEW/ (NVEC) at an average of $101.49 ($101.00–$101.54, $2.15M total) across 2 trades on 2026-09-08.
1 min readBAKER DANIEL A sold $623K of NVEC
BAKER DANIEL A sold 5,731 shares of NVE CORP /NEW/ (NVEC) at an average of $108.74 ($107.00–$110.00, $0.62M total) across 3 trades over 2026-08-25 to 2026-08-27.
1 min readBAKER DANIEL A sold $182K of NVEC
BAKER DANIEL A sold 1,500 shares of NVE CORP /NEW/ (NVEC) at $121.50 ($0.18M total) on 2026-08-17.
1 min readNVE CORP /NEW/ (NVEC): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
NVE CORP /NEW/ (NVEC) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.07 Submission of Matters to a Vote of Security Holders. Our 2026 Annual Meeting of Shareholders was held August 6, 2026, for the following purposes: (1) elect seven directors; (2) advisory approval of named executive officer compensation; and (3) ratify the selection of Bo
4 min read
Jim Cramer Stock Picks: Summit Therapeutics Is A 'Great Spec' - Carvana (NYSE:CVNA)
Carvana reported Q2 revenue of $7.38B, above $6.91B estimates, and EPS of 42 cents vs 36 cents, according to Benzinga Pro. Jim Cramer highlighted Summit Therapeutics as a “great spec” after it reported a smaller-than-expected Q2 loss but said it lacks working capital for 12 months. He also discussed Forgent Power, NVE, and Reddit.
7 min readBAKER DANIEL A sold $2.3M of NVEC
BAKER DANIEL A (President & CEO) sold 20,000 shares of NVE CORP /NEW/ (NVEC) at an average of $114.91 ($114.08–$117.57, $2.30M total) across 3 trades over 2026-07-27 to 2026-07-29.
2 min readNVE (NVEC) Earnings Put Valuation Back In Focus As DCF Tells A Different Story
Simply Wall St reports NVE (NVEC) first-quarter results: revenue of $11.03 million, net income of $6.39 million, and EPS of $1.32 from continuing operations. The stock closed at $117.55, with a 31.6x P/E. The article cites a DCF fair value estimate of $35.32 per share.
7 min readWe told you first: Picked by our AI in July, this nanotech soared +55% YESTERDAY By Investing.com
Investing.com reports that NVE Corporation (NASDAQ: NVEC) surged about 55% in a single session after its earnings. The article cites Q1 results: revenue up 81% to $11.0 million, net income up 79% to $6.39 million, and a $1.00-per-share quarterly dividend. It also mentions other ProPicks AI gainers and a U.S. forced-labor tariff update.
7 min readNVE (NVEC) Q1 2027 Earnings Call Transcript
NVE Corp (NVEC) Q1 2027 results showed net income up 79% to $6.39 million, or $1.32 per diluted share, on higher revenue. Operating expenses rose mainly from performance-based compensation, while expense as a % of revenue fell to 15% from 19%. Cash and marketable securities rose to $43.9 million. The company launched two MRI-safe wafer-level chip scale sensors and announced CEO succession.
12 min readNVE CORP /NEW/ (NVEC): Results of Operations and Financial Condition
NVE CORP /NEW/ (NVEC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 nve_ex99z1.htm PRESS RELEASE Press Release NVE Corporation Reports First Quarter Results and Announces Quarterly Dividend Revenue increases 81% and net income increases 79% EDEN PRAIRIE, Minn.—July 22, 2026—NVE Corporation (Nasdaq: NVEC) announced today financial result
4 min read